EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

COL1A1::PDGFB fusion‐associated uterine fibrosarcoma: A case report and review of the literature

Simone Rota iD, Andrea Franza, Chiara Fabbroni, Biagio Paolini, Francesca Gabriella Greco, Alessandra Alessi, Barbara Padovano, Paolo Casali, Roberta Sanfilippo

Cancer Reports · 2024

DOI: 10.1002/cnr2.1969 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Reports, 2024. Verfasst von Simone Rota und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. Hauptthemen laut MEDLINE: Dermatofibrosarcoma, Leiomyosarcoma, Skin Neoplasms, Fibrosarcoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mesenchymal neoplasms of the uterus encompass a diverse group of tumors, with varying characteristics and origins, collectively accounting for 8% of uterine malignancies. The most common variants include uterine leiomyosarcoma, low‐grade and high‐grade endometrial stromal sarcoma, adenosarcoma, and undifferentiated sarcoma. Clinical presentation is often nonspecific and can lead to delayed diagnosis. Uterine sarcomas are generally aggressive, resulting in poorer prognosis compared to carcinomas. Recent advances in molecular techniques, such as next‐generation sequencing (NGS), have led to the identification of new subtypes of uterine sarcomas, including COL1A1::PDGFB fusion‐associated fibrosarcoma, which has a specific chromosomal translocation t(17;22)(q22;q13). Imatinib, a tyrosine kinase inhibitor (TKI), is an effective treatment for dermatofibrosarcoma protuberans (DFSP), marked by this translocation. Case We present the case of a 42‐year‐old woman diagnosed with COL1A1::PDGFB fusion‐associated uterine fibrosarcoma. The patient underwent total hysterectomy and excision of the tumor, initially misdiagnosed as a low‐grade leiomyosarcoma. Subsequent histological examination, immunohistochemistry, and fluorescence in situ hybridization (FISH) confirmed the diagnosis. After 10 months, disease recurrence was detected, and Imatinib therapy was initiated at a dose of 400 mg daily. An allergic reaction led to a temporary discontinuation, but upon resumption with appropriate medication, a positive radiological response was observed. The patient achieved a complete remission after 2 years and is still on Imatinib treatment.

Conclusions

COL1A1::PDGFB fusion‐associated uterine fibrosarcoma is an extremely rare mesenchymal neoplasm. In a case we present herein, we treated a patient with imatinib as first‐line medical therapy. The patient is currently in complete remission after 37 months from treatment start. To the best of our knowledge, this represents a unique observation. We also provide a detailed literature review of the published cases so far. Prospective case series are needed to further understand the natural history of these tumors and optimize treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatofibrosarcomaLeiomyosarcomaSkin NeoplasmsFibrosarcomaSoft Tissue NeoplasmsFemaleHumansAdultProto-Oncogene Proteins c-sisImatinib MesylateIn Situ Hybridization, FluorescenceNeoplasm Recurrence, LocalTranslocation, GeneticUterus

Stichwörter der Autor:innen

COL1A1::PDGFBImatinibfibrosarcomasoft tissue sarcomastranslocation t(17;22)(q22;q13)uterus

Substanzen

Proto-Oncogene Proteins c-sisImatinib Mesylate

Autor:innen und Institutionen

  • Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
  • Department of Interventional Radiology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Dei Tumori, Milan, Italy.
  • Department of Nuclear Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Medical Oncology, Università degli Studi, Milan, Italy.

ORCID-Profile: Simone Rota

Zitieren

APA

Rota, S., Franza, A., Fabbroni, C., Paolini, B., Greco, F. G., Alessi, A., Padovano, B., Casali, P., & Sanfilippo, R. (2024). COL1A1::PDGFB fusion‐associated uterine fibrosarcoma: A case report and review of the literature. Cancer Reports. https://doi.org/10.1002/cnr2.1969

Vancouver

Rota S, Franza A, Fabbroni C, Paolini B, Greco FG, Alessi A, et al. COL1A1::PDGFB fusion‐associated uterine fibrosarcoma: A case report and review of the literature. Cancer Reports. 2024. doi:10.1002/cnr2.1969

BibTeX
@article{Rota2024,
  author = {Rota, Simone and Franza, Andrea and Fabbroni, Chiara and Paolini, Biagio and Greco, Francesca Gabriella and Alessi, Alessandra and Padovano, Barbara and Casali, Paolo and Sanfilippo, Roberta},
  title = {COL1A1::PDGFB fusion‐associated uterine fibrosarcoma: A case report and review of the literature},
  journal = {Cancer Reports},
  year = {2024},
  doi = {10.1002/cnr2.1969}
}
Kostenlos starten →